Background Ursodeoxycholic acid is commonly used to treat intrahepatic cholestasis of
pregnancy, yet its largest trial detected minimal benefit for a composite outcome (stillbirth …

Intrahepatic cholestasis of pregnancy is a hepatic disorder characterized by pruritus and an
elevation in serum bile acid levels. Although intrahepatic cholestasis of pregnancy poses …

Background Intrahepatic cholestasis of pregnancy is associated with adverse perinatal
outcomes, but the association with the concentration of specific biochemical markers is …

Abstract [Grade A] PURPOSE AND SCOPE This guideline summarises the evidence
regarding the diagnosis, and the maternal and fetal risks of intrahepatic cholestasis of …

Intrahepatic cholestasis of pregnancy (ICP) is the most common hepatic disorder related to
pregnancy in women. It usually develops within the third trimester of pregnancy and …

This first Practice Guidance on Reproductive Health from the American Association for the
Study of Liver Diseases (AASLD) is intended to be a comprehensive reference on …

Objective This review aims to increase the knowledge of women's health care providers
regarding the diagnosis, management, and fetal risks associated with ICP. Results The …

The liver disorders unique to pregnancy include hyperemesis gravidarum, intrahepatic
cholestasis of pregnancy, acute fatty liver of pregnancy, and preeclampsia-associated …

Introduction Previous studies of fetal effects have suggested that intrahepatic cholestasis of
pregnancy is associated with a higher rate of adverse neonatal outcomes including preterm …

Studies on the risk factors for intrahepatic cholestasis of pregnancy (ICP) in a population-
based cohort are lacking. We assess the prevalence and risk factors of ICP in a Chinese …